HomeBusinessAurobindo Pharma recalls US drugs for manufacturing errors.

Aurobindo Pharma recalls US drugs for manufacturing errors.

Business

Published on

By lapaasindia
spot_img
  • The US Food and Drug Administration (USFDA) said that Aurobindo Pharma USA is recalling 9,504 bottles of medicine used to treat high blood pressure from the US market.
  • According to the USFDA, the lot was recalled because of “CGMP violations from current good manufacturing standards.”
  • The recalled Quinapril and Hydrochlorothiazide tablets were marketed in the US by Aurobindo Pharma USA and were made in India.

Latest articles

Others

Vivo remitted over ₹1 lakh crore outside India since its entry in India in 2014 : ED

The Enforcement Directorate (ED) has filed a charge sheet against Chinese phone maker Vivo,...
Others

Equity Mutual Fund Inflows Decline 22% To Rs 15,536 Crore In November

In November, India witnessed a 22.15% decline in equity mutual fund inflows to Rs...
Others

Zerodha earn Rs 2.3 In Revenue For Every Rupee Spent In FY23

Zerodha, led by Nithin and Nikhil Kamath, experienced a significant 37% increase in net...
Others

Google’s best Gemini demo was faked

Google showcased Gemini's multimodal capabilities in a video titled “Hands-on with Gemini: Interacting with...

More like this

Others

Vivo remitted over ₹1 lakh crore outside India since its entry in India in 2014 : ED

The Enforcement Directorate (ED) has filed a charge sheet against Chinese phone maker Vivo,...
Others

Equity Mutual Fund Inflows Decline 22% To Rs 15,536 Crore In November

In November, India witnessed a 22.15% decline in equity mutual fund inflows to Rs...
Others

Zerodha earn Rs 2.3 In Revenue For Every Rupee Spent In FY23

Zerodha, led by Nithin and Nikhil Kamath, experienced a significant 37% increase in net...

We help you to learn,understand and update all the current affairs related to the business and startup world.

© Lapaas Voice